ReviewEndocrine2013
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.
Cosimo Durante et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewEndocrine2013
Cosimo Durante et al.PubMed ↗Publisher ↗
No numbers read from the abstract.